Proteochemometric mapping of the interaction of organic compounds with melanocortin receptor subtypes

Molecular Pharmacology

Volumn 67, Issue 1, 2005, Pages 50-59

  Lapinsh, Maris ^a   Veiksina, Santa ^a   Uhlén, Staffan ^a   Petrovska, Ramona ^a   Mutule, Ilze ^a   Mutulis, Felikss ^a   Yahorava, Sviatlana ^a   Prusis, Peteris ^a   Wikberg, Jarl E S ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b Pharmaceutical Pharmacology   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHIMERIC PROTEIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 5 RECEPTOR; ORGANIC COMPOUND;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CHEMICAL MODEL; CHEMOMETRIC ANALYSIS; LIGAND BINDING; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEOMICS; RECEPTOR AFFINITY; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; THREE DIMENSIONAL IMAGING; WILD TYPE;

BASE SEQUENCE; BINDING SITES; CLONING, MOLECULAR; DNA PRIMERS; HUMANS; KINETICS; LIGANDS; MODELS, MOLECULAR; ORGANIC CHEMICALS; PROTEIN CONFORMATION; RECEPTOR, MELANOCORTIN, TYPE 1; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, CORTICOTROPIN; RECOMBINANT FUSION PROTEINS;

EID: 11244311579     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.002857     Document Type: Article

References (31)

1. Baroni M, Costantino G, Cruciani G, Riganelli D, Valigi R, and Clementi S (1993) Generating optimal linear PLS estimations (GOLPE): an advanced chemometric tool for handling 3D-QSAR problems. Quant Struct-Act Relat 12:9-20.
2. Chhajlani V, Muceniece R, and Wikberg JES (1993) Molecular cloning of a novel human melanocortin receptor. Biochem Biophys Res Commun 195:866-873.
3. Chhajlani V and Wikberg JES (1992) Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 309:417-420.
4. Eriksson L and Johansson E (1996) Multivariate design and modeling in QSAR. Chemom Intell Lab Syst 34:1-19.
5. Gantz I, Konda Y, Tashiro T, Shimoto Y, Miwa H, Munzert G, Watson SJ, DelValle J, and Yamada T (1993a) Molecular cloning of a novel melanocortin receptor. J Biol Chem 268:8246-8250.
6. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, DelValle J, and Yamada T (1993b) Molecular cloning, expression and gene localization of a fourth melanocortin receptor. J Biol Chem 268:15174-15179.
7. Geladi P and Kowalski BR (1986) Partial least-squares regression: a tutorial. Anal Chim Acta 185:1-17.
8. Haskell-Luevano C, Cone RD, Monck EK, and Wan YP (2001) Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. Biochemistry 40:6164-6179.
9. Horn F, Bettler E, Oliveira L, Campagne F, Cohen FE, and Vriend G (2003) GPCRDB information system for G protein-coupled receptors. Nucleic Acids Res 31:294-297.
10. Lapinsh M, Prusis P, Gutcaits A, Lundstedt T, and Wikberg JES (2001) Development of proteochemometrics: a novel technology for the analysis of drug-receptor interactions. Biochim Biophys Acta 1525:180-190.
11. Lapinsh M, Prusis P, Lundstedt T, and Wikberg JES (2002) Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands. Mol Pharm 61:1465-1475.
12. Lapinsh M, Prusis P, Mutule I, Mutulis F, and Wikberg JES (2003) QSAR and proteochemometric analysis of the interaction of a series of organic compounds with melanocortin receptor subtypes. J Med Chem 46:2572-2579.
13. Lundstedt T, Seifert E, Abramo L, Thelin B, Nyström Å, Pettersen J, and Bergman R (1998) Experimental design and optimization. Chemom Intell Lab Syst 42:3-40.
14. Mutulis F, Mutule I, Lapinsh M, and Wikberg JES (2002a) Reductive animation products containing naphthalene and indole moieties bind to melanocortin receptors. Bioorg Med Chem Lett 12:1035-1038.
15. Mutulis F, Mutule I, and Wikberg JES (2002b) N-Alkylaminoacids and their derivatives interact with melanocortin receptors. Bioorg Med Chem Lett 12:1039-1042.
16. Nickolls SA, Cismowski MI, Wang X, Wolff M, Conlon PJ, and Maki RA (2003) Molecular determinants of melanocortin 4 receptor ligand binding and MC4/MC3 receptor selectivity. J Pharmacol Exp Ther 304:1217-1227.
17. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, et al. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science (Wash DC) 289:739-745.
18. Prusis P, Lundstedt T, and Wikberg JES (2002) Proteochemometrics analysis of MSH peptide binding to melanocortin receptors. Protein Eng 15:305-311.
19. 3-receptor interactions reveals a novel method for the analysis of ligand-receptor interactions. Biochim Biophys Acta 1544:350-357.
20. Sandberg M, Eriksson L, Jonsson J, Sjöström M, and Wold S (1998) New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. J Med Chem 41:2481-2491.
21. Schioth HB, Chhajlani V, Muceniece R, Klusa V, and Wikberg JES (1996a) Major pharmacological distinction of the ACTH receptor from other melanocortin receptors. Life Sci 59:797-801.
22. Schioth HB, Muceniece R, and Wikberg JES (1996b) Characterisation of the melanocortin 4 receptor by radioligand binding. Pharmacol Toxicol 79:161-165.
23. Schioth HB, Muceniece R, Wikberg JES, and Chhajlani V (1995) Characterisation of melanocortin receptor subtypes by radioligand binding analysis. Eur J Pharmacol 288:311-317.
24. Sebhat IK, Martin WJ, Ye Z, Barakat K, Mosley RT, Johnston DB, Bakshi R, Palucki B, Weinberg DH, MacNeil T, et al. (2002) Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist. J Med Chem 45:4589-4593.
25. Vogelstein B and Gillespie D (1979) Preparative and analytical purification of DNA from agarose. Proc Natl Acad Sci USA 76:615-619.
26. Wikberg JES (2001) Melanocortin receptors: new opportunities in drug discovery. Exp Opin Ther Patents 11:61-76.
27. Wikberg JES, Lapinsh M, and Prusis P (2004) Proteochemometrics - a tool for modelling the molecular interaction space, in Methods and Principles in Medicinal Chemistry (Müller G and Kubinyi H eds) vol 22, pp 289-309, Wiley-VCH, Weinheim, Germany.
28. Wikberg JES, Muceniece R, Mandrika I, Prusis P, Lindblom J, Post C, and Skottner A (2002) New aspects on the melanocortins and their receptors. Pharmacol Res 42:393-420.
29. Wikberg JES, Mutulis F, Mutule I, Veiksina S, Lapinsh M, Petrovska R, and Prusis P (2003) Melanocortin receptors: ligands and Proteochemometrics modeling. Ann NY Acad Sci 994:21-26.
30. Wold S (1995) PLS for multivariate linear modeling, in Chemometric Methods in Molecular Design (van de Waterbeemd H ed) vol 2, pp 195-218, VCH Verlagsgesellschaft, Weinheim, Germany.
31. Yang YK, Fong TM, Dickinson CJ, Mao C, Li Y, Tota MR, Mosley R, Van Der Ploeg LH, and Gantz I (2000) Molecular determinants of ligand binding to the human melanocortin-4 receptor. Biochemistry 39:14900-14911.